DSM is pleased to announce that its unique blood pressure management
ingredient, tensVida™(1) (formerly known as TensGuard™(2)), won the NutrAward
for the most innovative, evidence-based health and nutrition ingredient.
Selected by a panel of industry experts, scientists and nutritionists, plus
votes from Nutracon attendees, tensVida saw off tough competition from two
other finalists to claim this prestigious award. The decision makes tensVida
the first ingredient to win industry awards in both the US and Europe.
Entries were judged against key criteria for scientific merit, efficacy and
market potential. Luc van-der-Heyden, business manager heart health, DSM
Functional Foods Marketing, explains why tensVida was successful: “As a well
known risk factor for coronary heart disease, kidney failure and stroke, high
blood pressure is a major global concern. TensVida represents a major
breakthrough to help maintain normal blood pressure. Opening up a new sector
in the functional foods market, tensVida enables manufacturers to develop a
wide range of food, beverage and dietary supplement products which can offer
specific heart health benefits.”
He further added: “We are thrilled with this news, particularly coming within
months of our Gold award for most innovative new health ingredient at Health
Ingredients Europe last November. This second prestigious award demonstrates
tensVida’s worldwide appeal and is a result of the dedicated research, hard
work and commitment of our global team. Plus we are already seeing early
commercial success in the US with Twinlab, Swanson and Total Nutrition all
recently launching products containing tensVida. Now, with international
recognition from two respected industry bodies, we are confident of its
continued success.
“Winning the NutrAward provides us with the ideal opportunity to also announce
that tensVida is the new name for TensGuard. This change is part of a global
strategy to align our portfolio of functional ingredients under our new
umbrella brand. The Vida family of ingredients has been created to bring
greater customer value by combining unparalleled quality, efficacy, scientific
research and consumer insight. The European launch for tensVida will take
place at Vitafoods International, Geneva, where DSM will also be chairing the
heart health forum.”
The product of advanced enzyme technology, tensVida is a milk-derived
tripeptide which helps to maintain healthy blood pressure within the normal
range. Tripeptides occur naturally in dairy products such as aged cheese and
cultured milk. Scientific studies show that milk-derived tripeptides with the
bioactive amino acid sequence IPP (isoleucine-proline-proline) can maintain
healthy blood pressure in people who have blood pressure within the normal
range. A world leader in enzyme technology, DSM uses advanced enzymatic
hydrolysis to release the maximum effectiveness of these potent bioactive
tripeptides to produce tensVida, today’s most concentrated lactotripeptide for
your heart health formulations. As today’s highest potency lactotripeptide,
tensVida requires only a low dosage to be effective, making it more adaptable
to your heart health formulations. tensVida is odourless, clean tasting, and
entirely water soluble, making it suitable for a wide range of food and
beverage applications. tensVida is also available in a granulated form, which
can be easily incorporated into tablets and capsules.
(1) tensVida™ is a trademark of Royal DSM N.V.
(2) TensGuard™
is a trademark of Royal DSM N.V.
